JPWO2020006229A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020006229A5
JPWO2020006229A5 JP2020573421A JP2020573421A JPWO2020006229A5 JP WO2020006229 A5 JPWO2020006229 A5 JP WO2020006229A5 JP 2020573421 A JP2020573421 A JP 2020573421A JP 2020573421 A JP2020573421 A JP 2020573421A JP WO2020006229 A5 JPWO2020006229 A5 JP WO2020006229A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
alkylene
haloalkyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020573421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530464A (ja
JP7565802B2 (ja
JP2021530464A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/039499 external-priority patent/WO2020006229A1/en
Publication of JP2021530464A publication Critical patent/JP2021530464A/ja
Publication of JPWO2020006229A5 publication Critical patent/JPWO2020006229A5/ja
Publication of JP2021530464A5 publication Critical patent/JP2021530464A5/ja
Priority to JP2024114813A priority Critical patent/JP7787250B2/ja
Application granted granted Critical
Publication of JP7565802B2 publication Critical patent/JP7565802B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573421A 2018-06-27 2019-06-27 炎症抑制用化合物 Active JP7565802B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024114813A JP7787250B2 (ja) 2018-06-27 2024-07-18 炎症抑制用化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862690788P 2018-06-27 2018-06-27
US62/690,788 2018-06-27
PCT/US2019/039499 WO2020006229A1 (en) 2018-06-27 2019-06-27 Compounds for inhibition of inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024114813A Division JP7787250B2 (ja) 2018-06-27 2024-07-18 炎症抑制用化合物

Publications (4)

Publication Number Publication Date
JP2021530464A JP2021530464A (ja) 2021-11-11
JPWO2020006229A5 true JPWO2020006229A5 (https=) 2022-07-04
JP2021530464A5 JP2021530464A5 (https=) 2022-07-04
JP7565802B2 JP7565802B2 (ja) 2024-10-11

Family

ID=68987150

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020573421A Active JP7565802B2 (ja) 2018-06-27 2019-06-27 炎症抑制用化合物
JP2024114813A Active JP7787250B2 (ja) 2018-06-27 2024-07-18 炎症抑制用化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024114813A Active JP7787250B2 (ja) 2018-06-27 2024-07-18 炎症抑制用化合物

Country Status (8)

Country Link
US (1) US20210267996A1 (https=)
EP (1) EP3813805A4 (https=)
JP (2) JP7565802B2 (https=)
CN (1) CN112512515B (https=)
AU (2) AU2019293232B2 (https=)
BR (1) BR112020025018A2 (https=)
CA (1) CA3103432A1 (https=)
WO (1) WO2020006229A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113189340A (zh) * 2020-01-14 2021-07-30 中国医学科学院基础医学研究所 细胞焦亡通路在细胞治疗中的用途
WO2021257880A1 (en) * 2020-06-18 2021-12-23 Spring Discovery, Inc. Use of aldh modulators or gasdermin d inhibitors for prevention and treatment of aging and aging-related disorders and for boosting an immune system
CN112011499B (zh) * 2020-09-10 2022-06-03 徐州医科大学 一种制备细胞外囊泡的方法及其应用
US11065214B1 (en) 2020-09-18 2021-07-20 Spring Discovery, Inc. Combination therapies with disulfiram
EP4112051A1 (en) * 2021-06-30 2023-01-04 Op2 Drugs Anethole trithione for the treatment of vasculitides
CN113462653B (zh) * 2021-07-05 2022-10-04 东北农业大学 抗猪Gasdermin D蛋白单克隆抗体、分泌该单克隆抗体杂交瘤细胞株及其应用
AU2022309856A1 (en) * 2021-07-15 2024-01-18 Genentech, Inc. Therapeutic compounds and methods
CN113577288A (zh) * 2021-09-15 2021-11-02 皖南医学院第一附属医院（皖南医学院弋矶山医院） Mst4相关物质在制备治疗脑出血后神经炎症反应的药物中的应用
CN115819548B (zh) * 2021-11-16 2023-09-01 北京美德泰康生物科技有限公司 一种检测炎症相关疾病的标志物和方法
CN115947691B (zh) * 2022-03-01 2024-08-16 四川大学 哒嗪砜类衍生物及其用途
LU501764B1 (en) * 2022-03-31 2023-10-02 Leibniz Inst Fuer Naturstoff Forschung Und Infektionsbiologie E V Hans Knoell Inst Hki Gasdermin e expression in human t cells as a marker for proinflammatory t cell functions
CN115429794B (zh) * 2022-09-16 2023-11-17 温州医科大学附属口腔医院 3-甲基吲哚二甲基氨基二硫代酸酯在制备防治牙周炎药物的用途
CN119285558A (zh) * 2023-07-10 2025-01-10 四川大学 一类新型gsdmd抑制剂及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870101A (en) * 1987-03-17 1989-09-26 Merrell Dow Pharmaceuticals Inc. Method of inhibiting interleukin-1 release
IL122892A0 (en) * 1998-01-11 1998-08-16 Yeda Res & Dev Pharmaceutical compositions comprising a thiocarbamate
US6548540B2 (en) * 1998-09-08 2003-04-15 Charlotte-Mecklenburg Hospital Authority Method of treating cancer using dithiocarbamate derivatives
NZ545724A (en) * 2003-03-18 2007-11-30 Protemix Corp Ltd Use of a copper chelator for preventing and/or treating cardiovascular disease and/or associated heart failure
EP2101567A4 (en) * 2007-01-18 2010-04-21 Univ Utah Res Found COMPOSITIONS AND METHODS FOR DETECTING, TREATING OR PREVENTING REDUCED STRESS
EP2214709A4 (en) * 2007-11-08 2011-05-11 Univ Utah Res Found USE OF ANGIOGENESIS ANTAGONISTS IN DISEASES WITH ANOMAL VENEER PREPARATION
US20100137247A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100135983A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
EP2734240B1 (en) * 2011-07-18 2018-03-21 University Of Kentucky Research Foundation Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells
GB201804514D0 (en) * 2018-03-21 2018-05-02 Ucl Business Plc Treatment of pyroptosis

Similar Documents

Publication Publication Date Title
JP2021530464A5 (https=)
JPWO2020006229A5 (https=)
JP6929425B2 (ja) ピペリジニルインドール誘導体の新規な使用
US12370195B2 (en) Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
RU2503668C2 (ru) Фармацевтические комбинации антагониста рецептора ангиотензина и ингибитора nep
US20210000834A1 (en) Treatment of focal segmental glomerulosclerosis with ccr2 antagonists
WO2001076573A2 (en) Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
EP3522880B1 (en) Methods of treating acute kidney injury
US20190314382A1 (en) Compounds and pharmaceutical compositions thereof for the treatment of inflammatory diseases
US20100099642A1 (en) Tgf-beta stimulant and further agent to reduce side effects
JP5341521B2 (ja) タンパク質と結合パートナーとの相互作用を阻害するための化合物及び方法
KR20220127826A (ko) 화합물 및 α1-항트립신 결핍의 치료를 위한 이의 용도
JP2016523943A (ja) 糸球体疾患の治療に使用するためのロスマピモド
WO2021116706A1 (en) COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
AU2018347447B2 (en) Methods and compositions for treating pruritus, xerosis, and associated disease using CCR3-inhibitors
Chen et al. Discovery of potent and specific CXCR3 antagonists
Nick Deferasirox (Exjade®, ICL670) preclinical overview
US20120100204A1 (en) TGF-Beta Stimulating Agent Compositions and Combinations
JP2007518768A (ja) 有機化合物の組み合わせ物
JP7854001B2 (ja) α１－アンチトリプシン欠乏症の処置のための組成物およびそれらの使用
Omran et al. PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis
RU2023122618A (ru) Фармацевтическая композиция для предупреждения или лечения фиброза
WO2022263816A1 (en) COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
WO2017170860A1 (ja) ヒートショックプロテイン４７阻害剤
WO2025037010A1 (en) Fused piperidinyl bicyclic and related compounds for use in the treatment of diseases